Aliyev's meeting with Baerbock is held
17:21
Home page Health |
The Oxford coronavirus vaccine shows a strong immune response in adults in their 60s and 70s, raising hopes that it can protect age groups most at risk from the virus.
Axar.az reports that researchers say the Lancet phase two findings, based on 560 healthy adult volunteers, are "encouraging".
They are also testing whether the vaccine stops people developing Covid-19 in larger, phase three trials.
Early results from this crucial stage are expected in the coming weeks.
Date
2020.11.19 / 23:12
|
Author
Axar.az
|